Clinical Trial Update: Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dose intensification in patients with relapsed, refractory germ cell tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumors

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Germ Cell Tumors | Phase 2 | Status: COMPLETED